| Authors: |
Campbell KM; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA), Los Angeles, CA, 90095, USA.; These authors contributed equally to this work.; Senior author.; Lead Contact., Steiner G; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; These authors contributed equally to this work., Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA., Ribas A; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA), Los Angeles, CA, 90095, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, 94129, USA.; Department Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA., Kalbasi A; Department Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Department of Radiation Oncology, UCLA, CA, 90095, USA.; Senior author. |
